Daniel Friedman is an Oncology physician affiliated with Montefiore Medical Center. OpenAlex indexes 6 publications with 265 citations (h-index 1); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
60 E 208th St
Bronx, NY 104672702
Telephone
718-405-1700Registry record last updated 8 Jul 2007.
Clinical trials
- Conduction System Pacing With INGEVITY+
Sponsor: Duke University
- Telephone-Based Support Programs for People With Epilepsy
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20252 payments
- Daiichi Sankyo Inc.Program year20253 payments
- Janssen Biotech, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
44.6%Estrogen Agonist/Antagonist9.9%Tamoxifen Citrate100%Part D≥13 patientsAntimetabolite9.3%Hydroxyurea79%Droxia21%Part D<11 patients+ 5 more classes in this area
Blood & clotting
31%Factor Xa inhibitor26.7%Eliquis77%Xarelto16%Fondaparinux Sodium7%Part D<11 patientsVitamin K antagonist4.3%Warfarin Sodium100%Part D<11 patientsNervous system
12%Opioid Agonist10.3%Oxycodone Hcl51%Oxycodone-Acetaminophen26%Morphine Sulfate Er23%Part D<11 patientsBenzodiazepine1.6%Clonazepam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Michelle Gong, MD
Montefiore Medical Center
Sheryl Haut, MD
Montefiore Medical Center
Andreas Kaubisch, MD
Montefiore Medical Center
Lewis Eisen, MD
Montefiore Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”